Clinical Predictors of Functioning in Persons with Acquired Immunodeficiency Syndrome

Medical Care

Volumn 34, Issue 6, 1996, Pages 610-623

  Wilson, Ira B ^a   Cleary, Paul D ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Functional status; Health related quality of life; HIV; Outcomes

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISABLED PERSON; FEMALE; GROUP PRACTICE; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HUMAN; MALE; MEDICAL AUDIT; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; REPRODUCIBILITY; STANDARD; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; BOSTON; CROSS-SECTIONAL STUDIES; DISABLED PERSONS; FEMALE; GROUP PRACTICE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH STATUS INDICATORS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENT CLINICS, HOSPITAL; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 0030160758     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199606000-00010     Document Type: Article

References (60)

1. Deyo RA, Patrick DL. Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care 1989;27(suppl):S254.
2. Wilson IB, Kaplan S. Clinical practice and patients' health status: How are the two related? Med Care 1995;33(suppl):AS209-AS214.
3. Wasson J, Keller A, Rubenstein L, et al. Benefits and obstacles of health status assessment in ambulatory settings: The clinicians point of view. Med Care 1992;30:MS42.
4. Starr TJ, Pearlman RA, Uhlmann RF. Quality of life and resuscitation decisions in elderly patients. J Gen Intern Med 1986;1:373.
5. Presant CA. Quality of life in cancer patients: Who measures what? Am J Clin Oncol 1984;7:571.
6. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988;57:109.
7. Uhlmann RF, Pearlman RA. Perceived quality of life and preferences for life-sustaining treatment in older adults. Arch Intern Med 1991;151:495.
8. Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. J Clin Epidemiol 1992;45:743.
9. Pearlman RA, Uhlmann RF. Quality of life in chronic diseases: Perceptions of elderly patients. J Gerontol 1988;43:M25.
10. Nelson E, Conger B, Douglass R, et al. Functional health status levels of primary care patients. JAMA 1983;249:3331.
11. Nerenz DR, Repasky DP, Whitehouse FW, Kahkonen DM. Ongoing assessment of health status in patients with diabetes mellitus. Med Care 1992;30(suppl):MS112.
12. Calkins DR, Rubenstein LV, Cleary PD, et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med 1991;114:451.
13. Nielson AC, Williams TA. Depression in ambulatory medical patients: Prevalence by self-report questionnaire and recognition by nonpsychiatric physicians. Arch Gen Psych 1980;37:999.
14. Kessler LG, Amick BC, III, Thompson J. Factors influencing the diagnosis of metal disorder among primary care patients. Med Care 1985;23:50.
15. Seller RH, Blascovich J, Lenkei E. Influence of stereotypes in the diagnosis of depression by family practice residents. J Fam Pract 1981;12:849.
16. Goldberg D, Steele JJ, Johnson A, Smith C. Ability of primary care physicians to make accurate ratings of psychiatric symptoms. Arch Gen Psych 1982;39:829.
17. Kessler LG, Cleary PD, Burke JD. Psychiatric disorders in primary care: Results of a follow-up study. Arch Gen Psych 1985;42:583.
18. Haas JS, Weissman JS, Cleary PD, et al. Discussion of preferences for life-sustaining care by persons with AIDS: Predictors of failure in patient-physician communication. Arch Intern Med 1993;153:1241.
19. Bedell SE, Delbanco TL. Choices about cardiopulmonary resuscitation in the hospital: When do physicians talk with patients? N Engl J Med 1984;310:1089.
20. Seckler AB, Meier DE, Mulvihill M, Cammer BE. Substituted judgment: How accurate are proxy predictions? Ann Intern Med 1991;115:92.
21. Uhlmann RF, Pearlman RA, Cain KC. Understanding of elderly patients' resuscitation preferences by physicians and nurses. West J Med 1989;150:705.
22. Zweibel NR, Cassel CK. Treatment choices at the end of life: A comparison of decisions by older patients and their physician-selected proxies. The Gerontologist 1989;29:615-621.
23. Uhlmann RF, Pearlman RA, Cain KC. Physicians' and spouses' predictions of elderly patients' resuscitation preferences. J Gerontol 1988;43:M115.
24. Ouslander JG, Tymchuk AJ, Rahbar B. Health care descisions among elderly long-term care residents and their potential proxies. Arch Intern Med 1989;149:1367.
25. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. JAMA 1995;273:59.
26. Cleary PD, Wilson IB, Fowler FJ, Jr. Health-related quality of life in HIV-infected persons: A conceptual model. In: Dimsdale JE, Baum A, eds. Quality of life in behavioral research. Hillsdale, NJ: Lawrence Erlbaum Associates, 1995:191.
27. Cleary PD, Wilson IB, Fowler FJ. A theoretical framework for assessing and analyzing health-related quality of life. In: Albrecht G, ed. Advances in medical sociology. Greenwich, CT: JAI Press, 1994:23.
28. Massachusetts AIDS Surveillance Monthly Update. AIDS surveillance program. Boston, MA: Massachusetts Department of Public Health, 1991.
29. Fowler FJ, Massagli MP, Weissman J, Seage GR, Cleary PD, Epstein A. Some methodological lessons for surveys of persons with AIDS. Med Care 1992;30:1059.
30. Jette AM, Davies AR, Cleary PD, et al. The functional status questionnaire: Reliability and validity when used in primary care. J Gen Intern Med 1986;1:143.
31. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
32. Cleary PD, Fowler FJ, Weissman J, et al. Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care 1993;31:569.
33. Holland JC, Tross S. The psychosocial and neuropsychiatric sequelae of the acquired immune deficiency syndrome and related disorders. Ann Intern Med 1985;103:760.
34. Perry S. HIV-related depression. In: Price R, Perry S, eds. HIV, AIDS, and the Brain. New York, NY: Raven Press, 1993:233.
35. Lyketsos CG, Hoover DR, Guccione MS, et al. 27 depressive symptoms as predictors of medical outcomes in HIV infection. JAMA 1993;270:2563.
36. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 1993;270:2568.
37. Serwadda D, Sewankambo NK, Carswell JW, Bayley AC, Tedder RS, Weiss RA, et al. Slim disease: A new disease in Uganda and its association with HTLV-III infection. Lancet 1985;2:849-852.
38. Kotler DP, Tierney AR, Wang J, et al. The magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444.
39. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992;327:329.
40. Keusch GT, Thea DM. Malnutrition in AIDS. Med CHn North Am 1993;77:795.
41. Gorbach L, Knox TA, Roubenoff R. Interactions between nutrition and infection with human immunodeficiency virus. Nutr Rev 1993;51:226.
42. Coodley GO, Loveless MO, Merrill TM. The HlV wasting syndrome: A review. J AIDS 1994;7:681-694.
43. Macallan DC, Noble C, Baldwin C, et al. Enerty expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995;333:83.
44. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994;121:393.
45. Oster MH, Enders SR, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994:121:400.
46. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatments of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. N Engl J Med 1987; 317:185.
47. Wu AW, Mathews WC, Brysk LT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J AIDS 1990;3:683.
48. Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The quality of well-being scale: Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989;27:S27.
49. Lenderking WR, Gelber RD, Cotton DJ, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med 1994; 330:738.
50. Gelber RD, Lenderking WR, Cotton DJ, et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. Ann Intern Med 1992;116:961.
51. Wu AW, Rubin HR, Mathews WC, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. J AIDS 1993;6:452.
52. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Recombinant human erythropoietin treatment: Investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Arch Intern Med 1993;153:2669.
53. Henry DH, Beali GN, Benson CA, et al. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy: Overview of four clinical trials. Ann Intern Med 1992;117:739.
54. Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488.
55. Miles SA, Golde DW, Mitsuyasu RT. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies. Hematol Oncol Clin North Am 1991;5:267.
56. Miles SA, Mitsuyasu RT, Moreno J, et al. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 1991;77:2109.
57. McFadden ER, Gilbert IA. Asthma. N Engl J Med 1992;327:1928.
58. Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 1993;328:1017.
59. Rubenstein LV, Calkins DR, Young RT, et al. Improving patient function: A randomized trail of functional disability screening. Ann Intern Med 1989;111:836.
60. Kazis LE, Callahan LF, Meenan RF, Pincus T. Health status reports in the care of patients with rheumatoid arthritis. J Clin Epidemiol 1990;43:1243.